Author:
Eksborg Staffan,Hardell Lennart,Bengtsson Nils-Olof,Sjödin Marie,Elfsson Birgitta
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Mouridsen H T, Alfthan O, Bastholt L, Bergh J, Dalmark M, Eksborg S, Hellsten S, Kjaer M, Peterson C, Skovsgard T, Sprensen J B, Tropé C, Aabo K: Current status of epirubicin (Farmorubicin) in the treatment of solid tumours.Acta Oncologia
29, 257 (1990).
2. Dixon A R, Robertson J F R, Athanassiou E, Jackson L, Blarney R W: Weekly Low Dosage Epirubicin in Advanced Breast Cancer.Eur J Cancer
26, 847 (1990).
3. Legha S S, Benjamin R S, Mackay B, Ewer M, Wallace S, Valdivieso M, Rasmussen S L, Blumenschein G R, Freireich E J: Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion,Ann Int Med
96, 133(1982).
4. Shapira J, Gotfried M, Lishner M, Ravid M: Reduced Cardiotoxicity of Doxorubicin by a 6-Hour Infusion Regime - A Prospective Randomized Evaluation.Cancer
65, 870(1990).
5. Fronczak A, Drzewoski J, Polakowski P: Comparative Studies of Doxorubicin and 4’-Epirubicin Effects on Cardiovascular System in Rabbits.Polish J Pharmacol Pharm
41, 597 (1989).
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献